Impact of apremilast on quality of life in Behcet's syndrome: analysis of the phase 3 RELIEF study

Creative Commons License

HATEMİ G., Mahr A., Takeno M., Kim D., MELİKOĞLU M., Cheng S., ...Daha Fazla

RMD OPEN, cilt.8, sa.2, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1136/rmdopen-2022-002235
  • Dergi Adı: RMD OPEN
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
  • Anahtar Kelimeler: Behcet Syndrome, Systemic vasculitis, Patient Reported Outcome Measures, DISEASE-ACTIVITY, RELIABILITY, VALIDITY, SF-36
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Objective To assess apremilast's impact on patient quality of life (QoL) in active Behcet's syndrome and correlations between improvement in patients' QoL and efficacy measures in the phase 3 RELIEF study.